IRM vs KNSA · P/E 136, rev $3.97B vs P/E 53, rev $677.6M
Iron Mountain Incorporated (IRM) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the IRM and KNSA stock pages for the full models.
Not investment advice.